Search results
Found 30040 matches for
NIHR Health Technology Aassessment is funding a new study looking at the risks and benefits of first line osteoporosis medications (oral bisphosphonates) amongst patients suffering from chronic kidney disease, led by Associate Professor Daniel Prieto-Alhambra of NDORMS.
MSD Mediation Service
Building better workplace relationships and equipping people to manage conflict better.
New theory for spontaneous reporting of suspected adverse drug reactions to biological therapies
Adverse drug reactions, commonly known as side effects, place a significant burden on health services and account for patient deaths, disease, and extra costs in the UK and worldwide. This research is about the reporting of side effects of biologic medicines on patients.
UK Human Functional Genomics Initiative: Musculoskeletal Cluster
Our research will use genetics to improve our understanding and treatment of musculoskeletal diseases, such as osteoarthritis and carpal tunnel syndrome, which cause more years of disability and pain than any other disease class.
2022-2024 cohort
Find out about our 2022-2024 alumni.